Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Shasun Pharmaceuticals updates on JV agreement with Sequent Scientific


Friday, 11 Apr 2014 04:18am EDT 

Shasun Pharmaceuticals Ltd:Says Alivira Animal Health Limited, Joint venture (JV) with Sequent Scientific completed allotment of 7,400,000 equity shares to Shasun Pharmaceuticals in consideration for the transfer of the Shasun's Vizag Unit.Also allotted 2,114,165 shares to Devicam Capital LLP, an enterprise jointly owned by the promoters of Shasun Pharmaceuticals and Sequent Scientific for cash. 

Company Quote

337.05
11.05 +3.39%
1 Jul 2015